Figure 2.

LINC00922 was upregulated in lung cancer and predicted a poor prognosis. (A) Expression level of LINC00922 in 52 cases of lung cancer tissues and normal lung tissues determined by quantitative real-time polymerase chain reaction. (B) 52 lung cancer patients were divided into high-expression and low-expression group based on their LINC00922 level. (C) LINC00922 level in lung cancer with tumor size >3 cm and those ≤3 cm. (D) LINC00922 level in lung cancer patients in T1, T2, T3, and T4 stage. (E) Kaplan-Meier curve introduced based on LINC00922 level in lung cancer patients for survival analysis. (F) Receiver operating characteristic (ROC) curve introduced for the sensitivity and identity of LINC00922 in lung cancer diagnosis.